MONTREAL, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce the appointment of Ted Di Giorgio to its Board of Directors. “The entire Board of Directors joins me in welcoming Ted Di Giorgio. With his distinguished career as an audit partner, our board will benefit from his financial expertise, pragmatic approach, and deep understanding of complex business environments, including his experience guiding major Québec-based public companies. We expect M ...

UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it has engaged RedChip Companies (“RedChip”) to lead its investor relations efforts. “We are entering a transformative phase for ProPhase,” said Ted Karkus, CEO and Chairman of ProPhase Labs. “With the imminent commercialization of our BE-Smart™ esophageal cancer diagnostic, continued expansion of our Nebul ...

Strong Operational Performance Drives Revenue and Gross Profit GrowthSINGAPORE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced its interim financial results for the six months ended June 30, 2025. Key Strategic Developments On February 12, 2025, the Company’s wholly owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), received ISCC EU and ISCC PLUS cert ...

SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in the below November investor conferences. Details are as follows: Event: Guggenheim 2nd Annual Healthcare Innovation ConferenceDate: November 11, 2025Time: 8:00 AM ETFormat: Fireside Chat Event: Jefferies London Healthcare Conference Date: November 1 ...

MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging biomedical device companies focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Josh Ruben has joined the Company’s Board of Directors. “We are honored to welcome Josh Ruben to our Board of Directors,” said John Lai, Chief Execut ...

– Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will host a virtual key opinion leader (KOL) event for investors to discuss the clinical and real-world challenges of statin intolerance, its impact on patient outcomes, and the Company’s continued commitment to addressing this significant unmet need. The event will be led by LeAnne Bloedon, VP, Head of Cli ...

Core Insights - BeWhere Holdings Inc. has successfully connected an IoT tracking device to AST SpaceMobile's direct-to-device satellite network, marking a significant advancement in global connectivity [1][2] - The test conducted in New Brunswick, Canada, utilized a standard BeWhere LTE IoT device, demonstrating the ability to transmit data directly through AST SpaceMobile's BlueBird satellite [2][3] - This breakthrough allows standard low-power IoT devices to connect to satellite networks without the need for specialized hardware, potentially transforming industries such as logistics, agriculture, and natural resource management [3][4] Company Overview - BeWhere Holdings Inc. specializes in low-power 5G IoT asset tracking technology, focusing on creating cost-effective remote monitoring solutions [8][10] - The company has experienced rapid growth over the past six years, collaborating with Fortune 500 companies and deploying hundreds of thousands of trackers across various sectors [9][10] - BeWhere's tracking solutions enhance the capabilities of AI management platforms by increasing the number of connected devices, thereby expanding growth potential [10] Industry Impact - The successful connection of a commercial IoT device is a pivotal step towards eliminating global connectivity gaps, enabling seamless two-way communication for assets in remote areas [5][7] - AST SpaceMobile aims to build the first global cellular broadband network in space, designed to operate with standard mobile devices, addressing the connectivity needs of billions of unconnected users [11] - The collaboration between BeWhere, AST SpaceMobile, and Bell demonstrates the potential for industrial innovation in challenging geographical regions, enhancing applications in environmental monitoring and public safety [6][7]

New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreementTerumo to pay a total of $30 million to Orchestra BioMedOrchestra BioMed retains all development and distribution rights to Virtue SAB in all indicationsOrchestra BioMed recently initiated patient enrollment for the Virtue Trial, its U.S. pivotal IDE trial of Virtue SAB in the treatment of coronary in-stent restenosis (“ISR”) NEW HOPE, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Orchestra ...

01 Quantum to Speak at Global PKI Conference in MalaysiaOctober 28, 2025 8:00 AM EDT | Source: 01 Quantum Inc.Toronto, Ontario--(Newsfile Corp. - October 28, 2025) - 01 Quantum Inc. (TSXV: ONE) (OTCQB: OONEF) ("01 Quantum"), one of the first-to-market, enterprise level cybersecurity provider for the quantum computing era, announces that William Gee a Senior Advisor to 01 Quantum Inc. and Vice Chair of Asia PKI Consortium will represent 01 Quantum on a panel discussion as well as a breakout ses ...

Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to more than 20 regulatory approvals Dr Smith's appointment will accelerate Step Pharma's ‘pipeline in a product’ strategy, leveraging her clinical and regulatory expertise to advance dencatistat, afirst-in-class CTPS1 inhibitor across multiple cancer and blood disorder indicationsAppointment follows Step Pharma’s recently announced €38 million Series C financing Saint-Genis-Pouilly, France, ...